August 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This case report observed significant hair regrowth and improved alopecia in a 30-year-old woman with alopecia areata after treatment with Ayurvedic medicine and lifestyle changes, with no recurrence during a six-month follow-up.
July 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This case report describes the treatment of a 10-year-old girl with severe hair loss linked to Pitta-Kapha imbalance and Krimi using Ayurvedic medicines and lifestyle changes, which resulted in significant improvement within one month without laboratory tests.
July 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This case report describes a 10-year-old girl with severe hair loss who showed significant improvement through Ayurvedic treatments and dietary changes, including herbal medicines and scalp applications, after one month without laboratory investigations.
July 2026 in “International Journal of Applied Pharmaceutics” This review discusses the dermatological and systemic adverse effects of hair dye use, particularly focusing on the common allergen para-phenylenediamine, and reports no new clinical data.
June 2026 in “International Journal of Ayurvedic Medicine (Hyderabad)” This study found that Asthimajjapachak Churna provided significantly more therapeutic relief from hair fall than Shwadamshtradi Rasayana Churna in young females over 30 days.
June 2026 in “International Journal of Ayurvedic Medicine” The study found that Asthimajjapachak Churna led to greater improvement in managing hair fall among young females compared to Shwadamshtradi Rasayana Churna, particularly through alleviation of Asthigata dosha.
June 2026 in “British Journal of Dermatology” This study reported that dermatological adverse events are common in patients treated with amivantamab for non-small cell lung cancer, often impacting quality of life and requiring treatment modifications.
June 2026 in “British Journal of Dermatology” This case report discusses an atypical presentation of bullous pemphigoid in a young man potentially triggered by occupational chemical exposure, highlighting diagnostic challenges and effective treatment with clobetasol propionate and prednisolone, transitioning to mycophenolate mofetil.
April 2026 in “SHILAP Revista de lepidopterología” This case report illustrates that prompt diagnosis and treatment of myositis in an SLE patient can lead to symptom resolution and highlights this condition as a rare SLE complication.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study observed significant hair regrowth and near-complete restoration in a 32-year-old female with Alopecia Areata (Indralupta in Ayurveda) treated over two months with a comprehensive Ayurvedic regimen, suggesting potential effectiveness of these therapies for this condition.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This case report documented that a comprehensive Ayurvedic treatment, including therapies like Vamana and Jalaukavacharana, achieved significant hair regrowth in a 32-year-old female with Indralupta (Alopecia Areata) over two months without adverse effects.
January 2026 in “Acta Dermatovenerologica Alpina Pannonica et Adriatica” In this case report, a 62-year-old woman with suspected discoid lupus erythematosus experienced worsening skin and hair symptoms despite treatment with topical corticosteroids, immunomodulatory therapy, and hydroxychloroquine, leading to her referral to a tertiary dermatology center.
January 2026 in “Case Reports in Rheumatology” This case report described a woman with systemic lupus erythematosus and Type 2 diabetes who developed dermatomyositis, showing improvements in muscle strength and creatine kinase levels following treatment with rituximab.
This case report illustrates that prompt diagnosis and management of myositis, a rare manifestation of Systemic Lupus Erythematosus, can lead to favorable patient outcomes, as demonstrated by symptom resolution and normal electromyocardiography findings.
January 2026 in “Clinical Journal for Nurse Practitioners in Women s Health” In this article, it is explored how pregnancy-related physiologic changes can predispose women to dermatologic conditions affecting well-being, and it highlights the critical role of women’s health nurse practitioners in managing these conditions with attention to safety and efficacy in pregnant patients.
December 2025 in “Biomedicines” This source reviews the common skin-related side effects of tyrosine kinase inhibitors in treating endocrine cancers and emphasizes that proactive, multidisciplinary management can effectively control these adverse events without compromising cancer treatment efficacy.
November 2025 in “Pacific Journal of Medical Research” This study found that acute cutaneous lupus erythematosus, particularly malar rash, was the most common skin manifestation among SLE patients in Bangladesh, with significant occurrences of nonspecific lesions like alopecia and mucosal ulcers.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, researchers evaluated hair loss in 40 participants and identified key Ayurvedic and biochemical factors, finding frequent dietary incompatibilities and a high prevalence of low serum calcium, supporting an integrated approach emphasizing diet and scalp health.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, low serum calcium and dietary incompatibilities were linked to hair loss, supporting Ayurveda's connection between Asthi Dhatu and hair, and suggesting an integrative approach for prevention.
September 2025 in “Mansoura Journal of Chemistry” This study found that certain blood and urine markers, such as reduced hemoglobin and leukocyte counts and elevated proteinuria, are significant in diagnosing juvenile systemic lupus erythematosus, underscoring the need for further research to refine diagnostic criteria and improve patient outcomes.
August 2025 in “JEADV Clinical Practice” This case report describes the management of PRIDE complex, a skin and hair condition associated with EGFR inhibitor treatment like cetuximab, emphasizing that it does not require stopping the medication.
This case report describes a six-year-old child with congenital biotinidase deficiency whose symptoms, including breathlessness, alopecia, and hearing loss, were reversed with biotin supplementation.
August 2025 in “International Ayurvedic Medical Journal” The authors concluded that, in this case study, Dhatri Lauha, Brahma Rasayana, and Asthiposhaka Vati effectively managed hair fall without adverse reactions.
August 2025 in “Indian Dermatology Online Journal” This review discusses how metaphorical language in dermatology, particularly terms like "butterfly" and "moth," aids in diagnosing and understanding skin conditions by highlighting their distinctive clinical presentations and underlying pathophysiology.
This study highlights the increasing association between popular diets, unregulated supplements, and various skin disorders, emphasizing the need for clinicians to thoroughly assess dietary histories to manage nutrition-related skin issues effectively.
June 2025 in “OPAL (Open@LaTrobe) (La Trobe University)” This study found that anti-Ku-positive patients exhibit heterogeneous muscle features, primarily showing a myositis pattern with necrotizing fibers and vacuolar changes, and suggests autophagy may play a significant role in their pathogenesis.
This case study documents a 55-year-old male with advanced NSCLC who experienced toe-predominant paronychia and a papulopustular rash following dacomitinib treatment, with the causality tools indicating a "probable" link, yet the therapy continued successfully without dosage alteration.
March 2025 in “Indian Journal of Dermatology Venereology and Leprology” In this study, tofacitinib showed significant efficacy in treating alopecia totalis and universalis over a 6-month period, with notable hair regrowth outcomes, while younger age of onset and shorter treatment duration were linked to less effectiveness.
March 2025 in “Journal of the European Academy of Dermatology and Venereology” In a retrospective multicenter cohort study, this research observed that baricitinib was effective and well-tolerated in treating adult patients with alopecia areata, including those with severe cases, showing promise in improving outcomes over a 12-month period with manageable side effects.
January 2025 in “Global Journal of Medical Therapeutics” In this case report, a 28-year-old female developed allergic contact dermatitis from prolonged use of 5% topical minoxidil, suggesting that minoxidil itself may often be responsible for such reactions rather than propylene glycol.